Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Embla Medical hf (OtherOSSFF) and Molina Healthcare (MOH)
at www.tipranks.com (Thu, 22-Oct 9:50 AM)
ORIC sets Oct. 23 call to spotlight enozertinib Phase 1b data for first-line NSCLC with EGFR atypical mutations
Market Chameleon (Tue, 20-Oct 11:08 AM)
ORIC Pharmaceuticals: Buy Rating Reiterated on Strong Enosertinib Efficacy and Safety, Price Target Unchanged at $26
at www.tipranks.com (Mon, 19-Oct 7:25 AM)
Wells Fargo Remains a Buy on Oric Pharmaceuticals (ORIC)
at www.tipranks.com (Sun, 18-Oct 9:15 AM)
